| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3270072 | HPB | 2010 | 7 Pages |
Abstract
The 5 year survival was 13%, and median survival 17 months. Treatment mortality was 0%. Patients that responded to treatment (40%) had a median survival of 26 months. TAI provides good palliation but selection of patients is crucial.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Agneta Norén, Jozef Urdzik, Frans Duraj, Charlotte Ebeling Barbier, Britt-Mari Karlson, Ulf Haglund,